Skip to main content
Journal of Medical Genetics logoLink to Journal of Medical Genetics
. 1993 May;30(5):388–392. doi: 10.1136/jmg.30.5.388

Familial amyloidotic polyneuropathy in Sweden: a pedigree analysis.

U Drugge 1, R Andersson 1, F Chizari 1, M Danielsson 1, G Holmgren 1, O Sandgren 1, A Sousa 1
PMCID: PMC1016374  PMID: 8100581

Abstract

Extended genealogical studies were performed on the heredity patterns in Swedish patients with familial amyloidotic polyneuropathy (FAP) using Swedish historical archives. The population studied included 239 patients: 109 patients were linked to five large pedigrees and 80 patients belonged to 30 smaller pedigrees or nuclear families. In the remaining 50 cases, no genealogical links were found. Differences in mean ages of onset between the different pedigrees were found, although a considerable variation within the pedigrees was also present. There was a tendency for later ages of onset among older generations than younger ones: descendants of affected mothers seem to be more prone to anticipation in age of onset than descendants of affected fathers. Furthermore, there seems to be a tendency for earlier ages of onset among patients with a carrier mother than a carrier father. Some extended pedigrees, from the Skellefteå and Piteå areas, are presented in detail. The former go back into the middle of the 17th century. One important conclusion is that the mutational event may have occurred in late mediaeval times.

Full text

PDF
388

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ANDRADE C. A peculiar form of peripheral neuropathy; familiar atypical generalized amyloidosis with special involvement of the peripheral nerves. Brain. 1952 Sep;75(3):408–427. doi: 10.1093/brain/75.3.408. [DOI] [PubMed] [Google Scholar]
  2. Andersson R. Familial amyloidosis with polyneuropathy. A clinical study based on patients living in northern Sweden. Acta Med Scand Suppl. 1976;590:1–64. [PubMed] [Google Scholar]
  3. Brackenridge C. J. Familial correlations for age at onset and age at death in Huntington's disease. J Med Genet. 1972 Mar;9(1):23–32. doi: 10.1136/jmg.9.1.23. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Kito S., Itoga E., Kamiya K., Kishida T., Yamamura Y. Studies on familial amyloid polyneuropathy in Ogawa Village, Japan. Eur Neurol. 1980;19(3):141–151. doi: 10.1159/000115139. [DOI] [PubMed] [Google Scholar]
  5. Nakazato M., Steen L., Holmgren G., Kurihara T., Matsukura S., Kangawa K., Matsuo H. Structurally abnormal transthyretin causing familial amyloidotic polyneuropathy in Sweden. Clin Chim Acta. 1987 Aug 31;167(3):341–342. doi: 10.1016/0009-8981(87)90355-x. [DOI] [PubMed] [Google Scholar]
  6. Saraiva M. J., Costa P. P., Birken S., Goodman D. S. Presence of an abnormal transthyretin (prealbumin) in Portuguese patients with familial amyloidotic polyneuropathy. Trans Assoc Am Physicians. 1983;96:261–270. [PubMed] [Google Scholar]
  7. Tawara S., Nakazato M., Kangawa K., Matsuo H., Araki S. Identification of amyloid prealbumin variant in familial amyloidotic polyneuropathy (Japanese type). Biochem Biophys Res Commun. 1983 Nov 15;116(3):880–888. doi: 10.1016/s0006-291x(83)80224-1. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Medical Genetics are provided here courtesy of BMJ Publishing Group

RESOURCES